Literature DB >> 16953506

Perylenophthalocyanines.

Andrew N Cammidge1, Hemant Gopee.   

Abstract

The first perylenophthalocyanines have been synthesised using a Diels-Alder reaction between dialkylperylenes and fumaronitrile as the key step towards the dinitrile precursors. As expected the octaalkylperylenophthalocyanines show red-shifted absorption spectra. They are high melting solids that do not display mesophase behaviour at accessible temperatures. A 3:1 phthalocyanine/perylenophthalocyanine hybrid material, prepared by a mixed macrocyclisation reaction, presents an unusual board-like molecular profile. Its absorption maxima lie between those observed for the parent phthalocyanines and the symmetrical perylenophthalocyanines. The spectrum shows a characteristic split Q-band due to the reduced symmetry of the core. This material is non-mesogenic but is sufficiently soluble to permit processing and characterisation. The (1)H NMR spectrum indicates that at least two of the appended alkyl chains are displaced out of the macrocycle plane and lie in its shielding region--an arrangement that disfavours the face-to-face packing required for mesophase formation.

Entities:  

Year:  2006        PMID: 16953506     DOI: 10.1002/chem.200600874

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  2 in total

1.  Topological Control of Columnar Stacking Made of Liquid-Crystalline Thiophene-Fused Metallonaphthalocyanines.

Authors:  Hiroyuki Suzuki; Koki Kawano; Kazuchika Ohta; Yo Shimizu; Nagao Kobayashi; Mutsumi Kimura
Journal:  ChemistryOpen       Date:  2015-11-24       Impact factor: 2.911

Review 2.  Diels-Alder Cycloaddition to the Bay Region of Perylene and Its Derivatives as an Attractive Strategy for PAH Core Expansion: Theoretical and Practical Aspects.

Authors:  Aneta Kurpanik; Marek Matussek; Piotr Lodowski; Grażyna Szafraniec-Gorol; Michał Krompiec; Stanisław Krompiec
Journal:  Molecules       Date:  2020-11-17       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.